Excipient Database Should Help Take Mystery Out Of ICH Q3D Risk Assessments
The pharmaceutical industry is developing an excipient database to better enable industry to conduct risk assessments set out in the ICH Q3D guideline.
You may also be interested in...
While leveraging published data may help pharmaceutical manufacturers understand the general risks of using excipients with known elemental impurities, it is less helpful in understanding specific risks.
Regulatory members of the International Council on Harmonization have issued Q3D guidance on metal impurities that, while harmonized, differs in emphasis.
More flexibility on residual solvents obtained from FDA's Office of Generic Drugs.